644 filings
4
Stephan Toutain
2 May 24
PDS Biotechnology / Stephan Toutain ownership change
4:17pm
3
Stephan Toutain
2 May 24
PDS Biotechnology / Stephan Toutain ownership change
4:15pm
8-K
PDSB
PDS Biotechnology Corporation
2 May 24
PDS Biotech Appoints Stephan Toutain as Chief Operating Officer
6:01am
ARS
2023 FY
PDSB
PDS Biotechnology Corporation
29 Apr 24
Annual report to shareholders
7:25am
DEFA14A
PDSB
PDS Biotechnology Corporation
29 Apr 24
Additional proxy soliciting materials
7:15am
S-8
08a2d
28 Mar 24
Registration of securities for employees
5:26pm
8-K
vdi7ec9tfg8w
27 Mar 24
PDS Biotech Announces Clinical Strategy Update and Reports Full Year 2023 Financial Results
7:30am
8-K
gvzqs1ze7xb6w9jzi7p
13 Mar 24
Patent for composition of matter and use of Infectimune® based influenza vaccines granted in the United States
6:02am
SC 13G
sinhhqrf6x2x43o49
29 Jan 24
PDS Biotechnology / BlackRock ownership change
5:26pm
4
8yx5cf7 3y4w5sns
23 Jan 24
PDS Biotechnology / Kirk V. Shepard ownership change
4:33pm
3
a49sg9xly55n2c n4ms
23 Jan 24
PDS Biotechnology / Kirk V. Shepard ownership change
4:31pm
8-K
6wss5fuj7n
22 Jan 24
PDS Biotech Announces Retirement of Lauren V. Wood, M.D., and Appointment of Kirk V. Shepard, M.D., as Chief Medical Officer
5:10pm
4
g48rzcu3x31nqv5znqpt
4 Dec 23
PDS Biotechnology / Lars Boesgaard ownership change
6:14pm
3
22y5aozc 71o6tk23qgr
4 Dec 23
PDS Biotechnology / Lars Boesgaard ownership change
6:11pm
8-K
sftwv89kh
4 Dec 23
Other Events
4:02pm
8-K
4r9j ji7d
28 Nov 23
PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer
6:02am
S-8
um8u4liuloutpf
14 Nov 23
Registration of securities for employees
4:11pm